Schott Pharma stock after-hours at EUR 24.63: plus 0.82 percent after the Xetra close
Published on 10/05/2026 at 18:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Schott Pharma stock was at EUR 24.63 after-hours at 6:34 p.m. CEST on October 5, 2026, up plus 0.82 percent versus the Lang & Schwarz prior close of EUR 24.43. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Schott Pharma stock.
Trading in Frankfurt
The Lang & Schwarz quote was recorded at 6:34 p.m. CEST. The current price was EUR 0.20 above the prior close of EUR 24.43, with the quote showing a bid of EUR 24.50 and an ask of EUR 24.75.
Third-quarter results and guidance
In its August 12, 2026, Q3 FY2026 earnings call, SCHOTT Pharma reported group revenue of EUR 281.8 million, up 8.3 percent at constant currencies and 10 percent on a reported basis. Group EBITDA was EUR 75 million, corresponding to a 26.8 percent margin, compared with a 32.3 percent margin in Q3 FY2025. Management confirmed full-year 2026 guidance for revenue growth of 5 percent to 6 percent at constant currencies and an EBITDA margin of 27 percent to 28 percent. Yahoo Finance published the earnings-call transcript.
